GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Arcoma ARCOMA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

8.50

—

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 130.8m

FY2016FY2025

Net income

SEK 5.0m

FY2016FY2025

Free cash flow

SEK 13.1m

FY2016FY2025

Shareholders' equity

SEK 74.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 130.8mSEK 156.8mSEK 163.0mSEK 125.0mSEK 117.1mSEK 117.4mSEK 133.7mSEK 119.5mSEK 91.8mSEK 102.1m
Research and development—SEK 7.0mSEK 6.5mSEK 4.9mSEK 4.6mSEK 1.8mSEK 2.5mSEK 4.0mSEK 4.9m—
Operating incomeSEK 8.7mSEK 14.0mSEK 4.7mSEK 3.1m−SEK 8.2mSEK 2.3mSEK 9.1m−SEK 433,000−SEK 10.0m−SEK 12.9m
Net incomeSEK 5.0mSEK 11.2mSEK 2.6mSEK 1.9m−SEK 7.5mSEK 1.4mSEK 6.6m−SEK 1.6m−SEK 9.8m−SEK 11.6m
Diluted earnings per share0.350.850.190.14-0.580.110.52-0.13-0.78-1.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 96.7mSEK 80.5mSEK 82.0mSEK 100.3mSEK 79.3mSEK 95.0mSEK 83.3mSEK 76.3mSEK 68.1mSEK 71.3m
Cash and short-term investmentsSEK 35.3mSEK 13.4mSEK 5.0mSEK 9.7mSEK 4.8mSEK 8.6mSEK 2.2mSEK 7.8mSEK 4.5mSEK 5.2m
Total liabilitiesSEK 21.9mSEK 21.1mSEK 33.3mSEK 54.5mSEK 35.2mSEK 45.5mSEK 38.1mSEK 37.2mSEK 27.3mSEK 33.9m
DebtSEK 90,000SEK 59,000SEK 3.9mSEK 25.1mSEK 16.6mSEK 17.0mSEK 7.3mSEK 13.3mSEK 1.8mSEK 16.3m
Shareholders' equitySEK 74.7mSEK 59.3mSEK 48.7mSEK 45.9mSEK 44.0mSEK 49.5mSEK 45.2mSEK 39.0mSEK 40.8mSEK 37.3m
Shares outstanding14m13m13m13m13m13m13m13m13m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 18.7mSEK 18.8mSEK 19.2m−SEK 179,000−SEK 1.9mSEK 6.8mSEK 11.1mSEK 45,000−SEK 8.9m−SEK 4.7m
Capital spending−SEK 5.6m−SEK 6.8m−SEK 2.6m−SEK 4.2m−SEK 4.2m−SEK 11.7m−SEK 11.1m−SEK 916,000−SEK 3.1m−SEK 876,000
Free cash flowSEK 13.1mSEK 12.1mSEK 16.6m−SEK 4.3m−SEK 6.1m−SEK 4.9m−SEK 28,000−SEK 871,000−SEK 12.0m−SEK 5.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 31.6mSEK 31.1mSEK 34.7mSEK 29.9mSEK 31.4mSEK 34.9mSEK 36.8mSEK 31.9m
Operating incomeSEK 646,000SEK 1.4mSEK 2.1mSEK 2.2mSEK 36,000SEK 2.6mSEK 3.1mSEK 2.4m
Net incomeSEK 314,000SEK 811,000SEK 1.4mSEK 1.6mSEK 4,000SEK 2.0mSEK 718,000SEK 2.3m
Diluted earnings per share0.020.060.100.110.000.140.050.17
Cash from operations−SEK 2.0m—SEK 13.0m—SEK 7.0m−SEK 2.0mSEK 4.0mSEK 6.0m
Capital spending—−SEK 1.0m——−SEK 1.0m−SEK 2.0m−SEK 2.0m−SEK 1.0m
Free cash flow————SEK 6.0m−SEK 4.0mSEK 2.0mSEK 5.0m
Total assetsSEK 99.5mSEK 101.8mSEK 96.7mSEK 98.0mSEK 81.0mSEK 92.3mSEK 80.5mSEK 87.3m
Cash and short-term investmentsSEK 30.9mSEK 33.9mSEK 35.3mSEK 23.9mSEK 14.8mSEK 8.2mSEK 13.4mSEK 10.7m
Debt——SEK 90,000———SEK 59,000—
Shareholders' equitySEK 75.9mSEK 75.5mSEK 74.7mSEK 73.4mSEK 61.4mSEK 61.4mSEK 59.3mSEK 59.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.5%2.2%0.6%
Operating income40.6%30.6%—
Net income38.3%29.8%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin7.9%5.3%3.0%0.3%
Net margin5.6%3.6%1.8%-0.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.912.741.353.2-22.5206.037.9-108.8-9.7-3.4
Price to sales0.80.90.70.81.42.41.91.41.00.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.